RATIONALE: Specific brain structures have been suggested to be involved in impulsive responding assessed by a variety of operant tasks. Central serotonin (5-HT) function has also been widely implicated in impulsivity; however, little research has addressed the regional aspect of 5-HT roles in different impulsive indices of task performance. OBJECTIVE: We analyzed the relationships between acquisition and reversal learning in a go/no-go task as different behavioral measures of impulsivity and focal concentrations of 5-HT and its metabolites in the brain. MATERIALS AND METHODS: Rats administered with parachloroamphetamine (PCA) and vehicle were tested in both acquisition and reversal phases in a go/no-go visual discrimination task. Neurochemical analysis was performed to determine 5-HT concentrations in micropunched brain tissues. RESULTS: PCA administration induced regionally 5-HT depletion in the brain and impaired learning performance in both tests. For both tests, significant negative correlations between learning performance and 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) concentrations were observed in the medial prefrontal cortex (mPFC) and amygdala (Amyg). In contrast, significant negative correlations between learning performance and 5-HT and 5-HIAA concentrations were observed for the orbitofrontal cortex (OFC) exclusively in the reversal learning phase. CONCLUSIONS: The present data indicate that 5-HT neurotransmission to the mPFC and Amyg is involved in inhibitory control over responses to discriminated stimuli associated with the go/no-go paradigm common to both tests. In contrast, 5-HT neurotransmission to the OFC is especially involved in additional processes associated with reversal learning.
RATIONALE: Specific brain structures have been suggested to be involved in impulsive responding assessed by a variety of operant tasks. Central serotonin (5-HT) function has also been widely implicated in impulsivity; however, little research has addressed the regional aspect of 5-HT roles in different impulsive indices of task performance. OBJECTIVE: We analyzed the relationships between acquisition and reversal learning in a go/no-go task as different behavioral measures of impulsivity and focal concentrations of 5-HT and its metabolites in the brain. MATERIALS AND METHODS:Rats administered with parachloroamphetamine (PCA) and vehicle were tested in both acquisition and reversal phases in a go/no-go visual discrimination task. Neurochemical analysis was performed to determine 5-HT concentrations in micropunched brain tissues. RESULTS: PCA administration induced regionally 5-HT depletion in the brain and impaired learning performance in both tests. For both tests, significant negative correlations between learning performance and 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) concentrations were observed in the medial prefrontal cortex (mPFC) and amygdala (Amyg). In contrast, significant negative correlations between learning performance and 5-HT and 5-HIAA concentrations were observed for the orbitofrontal cortex (OFC) exclusively in the reversal learning phase. CONCLUSIONS: The present data indicate that 5-HT neurotransmission to the mPFC and Amyg is involved in inhibitory control over responses to discriminated stimuli associated with the go/no-go paradigm common to both tests. In contrast, 5-HT neurotransmission to the OFC is especially involved in additional processes associated with reversal learning.
Authors: W Sommer; C Möller; L Wiklund; A Thorsell; R Rimondini; H Nissbrandt; M Heilig Journal: Neuropsychopharmacology Date: 2001-04 Impact factor: 7.853
Authors: S Mobini; S Body; M-Y Ho; C M Bradshaw; E Szabadi; J F W Deakin; I M Anderson Journal: Psychopharmacology (Berl) Date: 2002-01-25 Impact factor: 4.530
Authors: D G LeMarquand; R O Pihl; S N Young; R E Tremblay; J R Séguin; R M Palmour; C Benkelfat Journal: Neuropsychopharmacology Date: 1998-10 Impact factor: 7.853
Authors: Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Rudolf N Cardinal; Trevor W Robbins Journal: Cereb Cortex Date: 2005-04-13 Impact factor: 5.357
Authors: Marina Boccardi; Rossana Ganzola; Roberta Rossi; Francesca Sabattoli; Mikko P Laakso; Eila Repo-Tiihonen; Olli Vaurio; Mervi Könönen; Hannu J Aronen; Paul M Thompson; Giovanni B Frisoni; Jari Tiihonen Journal: Hum Brain Mapp Date: 2010-03 Impact factor: 5.038
Authors: Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2017-07-06 Impact factor: 5.067
Authors: Mahesh Darna; Jonathan J Chow; Justin R Yates; Richard J Charnigo; Joshua S Beckmann; Michael T Bardo; Linda P Dwoskin Journal: Behav Brain Res Date: 2015-07-13 Impact factor: 3.332
Authors: Naomi A Fineberg; Marc N Potenza; Samuel R Chamberlain; Heather A Berlin; Lara Menzies; Antoine Bechara; Barbara J Sahakian; Trevor W Robbins; Edward T Bullmore; Eric Hollander Journal: Neuropsychopharmacology Date: 2009-11-25 Impact factor: 7.853